Inozyme Pharma Stock Options
| INZY Stock | USD 2.79 0.08 2.95% |
Inozyme Pharma's latest option contracts expiring on 2024-12-20 are carrying combined implied volatility of 1.01 with a put-to-call open interest ratio of 0.15 over 5 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-12-20. The total put volume is at 55.0, with calls trading at the volume of 55.0. This yields a 0.72 put-to-call volume ratio.
Open Interest Against 2024-12-20 Option Contracts
Inozyme Pharma option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Inozyme Pharma's lending market. For example, when Inozyme Pharma's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Inozyme Pharma, he or she must hedge the risk by shorting Inozyme Pharma stock over its option's life.
2024-12-20
The chart above shows Inozyme Pharma's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Inozyme Pharma's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Inozyme Pharma's option, there is no secondary market available for investors to trade.
Inozyme Pharma's option chain provides insight into all available option contracts written on Inozyme Pharma's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Inozyme Pharma's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Inozyme option contract.
In The Money vs. Out of Money Option Contracts on Inozyme Pharma
Analyzing Inozyme Pharma's in-the-money options over time can help investors to take a profitable long position in Inozyme Pharma regardless of its overall volatility. This is especially true when Inozyme Pharma's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Inozyme Pharma's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Inozyme Pharma's stock while costing only a fraction of its price.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inozyme Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Inozyme Pharma In The Money Call Balance
When Inozyme Pharma's strike price is surpassing the current stock price, the option contract against Inozyme Pharma stock is said to be in the money. When it comes to buying Inozyme Pharma's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Inozyme Pharma are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Inozyme Current Options Market Mood
Inozyme Pharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Inozyme Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Inozyme Pharma's options investors are not very successful. Inozyme Pharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Inozyme contract
Base on the Rule 16, the options market is currently suggesting that Inozyme Pharma will have an average daily up or down price movement of about 0.0631% per day over the life of the 2024-12-20 option contract. With Inozyme Pharma trading at USD 2.79, that is roughly USD 0.001761. If you think that the market is fully incorporating Inozyme Pharma's daily price movement you should consider buying Inozyme Pharma options at the current volatility level of 1.01%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Inozyme |
Purchasing Inozyme Pharma options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Inozyme calls. Remember, the seller must deliver Inozyme Pharma stock to the call owner when a call is exercised.
Inozyme Pharma Option Chain
When Inozyme Pharma's strike price is surpassing the current stock price, the option contract against Inozyme Pharma stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Inozyme Pharma's option chain is a display of a range of information that helps investors for ways to trade options on Inozyme. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Inozyme. It also shows strike prices and maturity days for a Inozyme Pharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | INZY Option Call 20-12-2024 2 | 100 | 2024-12-20 | 0.0 - 0.0 | 0.45 | In |
Call | INZY Option Call 20-12-2024 5 | 63 | 2024-12-20 | 0.0 - 0.0 | 0.05 | Out |
Put | INZY Option Put 20-12-2024 2 | 10 | 2024-12-20 | 0.0 - 0.0 | 0.2 | Out |
Put | INZY Option Put 20-12-2024 5 | 14 | 2024-12-20 | 0.0 - 0.0 | 2.22 | In |
Put | INZY Option Put 20-12-2024 7 | 0 | 2024-12-20 | 3.3 - 6.8 | 2.78 | In |
Inozyme Pharma Market Cap Over Time
Market Cap |
| Timeline |
Inozyme Total Stockholder Equity
Total Stockholder Equity |
|
Inozyme Pharma Corporate Management
| Henric Bjarke | VP COO | Profile | |
| MS MBA | CFO Officer | Profile | |
| Gayle Gironda | Senior Officer | Profile | |
| Soojin Kim | Senior Officer | Profile |
Additional Tools for Inozyme Stock Analysis
When running Inozyme Pharma's price analysis, check to measure Inozyme Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inozyme Pharma is operating at the current time. Most of Inozyme Pharma's value examination focuses on studying past and present price action to predict the probability of Inozyme Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inozyme Pharma's price. Additionally, you may evaluate how the addition of Inozyme Pharma to your portfolios can decrease your overall portfolio volatility.